| abstract |
The present disclosure relates to compounds of formula (I). Compounds of formula (II), Compounds of formula (III), Compounds of formula (IV), Compounds of formula (V), Compounds of formula (VI), Compounds of formula (VII), in particular inhibitors if AhR, pharmaceutical formulation comprising any one of the same, use of said compounds or compositions in treatment, in particular treatment of cancer. |